LLY r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lilly (Eli) R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	3,819,000,000
Mar 31, 2026	3,510,000,000
Dec 31, 2025	3,801,500,000
Sep 30, 2025	3,465,700,000
Jun 30, 2025	3,336,000,000
Mar 31, 2025	2,734,000,000
Dec 31, 2024	3,022,500,000
Sep 30, 2024	2,734,100,000
Jun 30, 2024	2,711,200,000
Mar 31, 2024	2,522,800,000
Dec 31, 2023	2,562,700,000
Sep 30, 2023	2,409,100,000
Jun 30, 2023	2,356,500,000
Mar 31, 2023	1,985,100,000
Dec 31, 2022	1,995,900,000
Sep 30, 2022	1,802,900,000
Jun 30, 2022	1,781,900,000
Mar 31, 2022	1,610,100,000
Dec 31, 2021	1,959,400,000
Sep 30, 2021	1,705,300,000
Jun 30, 2021	1,655,000,000
Mar 31, 2021	1,672,100,000
Dec 31, 2020	1,838,000,000
Sep 30, 2020	1,465,400,000
Jun 30, 2020	1,390,200,000
Mar 31, 2020	1,392,100,000
Dec 31, 2019	1,581,400,000
Sep 30, 2019	1,380,900,000
Jun 30, 2019	1,402,200,000
Mar 31, 2019	1,230,500,000
Dec 31, 2018	1,453,800,000
Sep 30, 2018	1,280,900,000
Jun 30, 2018	1,271,000,000
Mar 31, 2018	1,107,500,000
Dec 31, 2017	1,473,200,000
Sep 30, 2017	1,340,000,000
Jun 30, 2017	1,272,100,000
Mar 31, 2017	1,258,300,000
Dec 31, 2016	1,450,600,000
Sep 30, 2016	1,236,400,000
Jun 30, 2016	1,335,900,000
Mar 31, 2016	1,221,000,000
Dec 31, 2015	1,444,200,000
Sep 30, 2015	1,143,400,000
Jun 30, 2015	1,169,500,000
Mar 31, 2015	1,039,300,000
Dec 31, 2014	1,185,700,000
Sep 30, 2014	1,243,200,000
Jun 30, 2014	1,195,400,000
Mar 31, 2014	1,109,300,000
Dec 31, 2013	1,475,400,000
Sep 30, 2013	1,377,400,000
Jun 30, 2013	1,330,400,000
Mar 31, 2013	1,348,100,000
Dec 31, 2012	1,463,100,000
Sep 30, 2012	1,342,800,000
Jun 30, 2012	1,320,700,000
Mar 31, 2012	1,151,500,000
Dec 31, 2011	1,355,300,000
Sep 30, 2011	1,280,900,000
Jun 30, 2011	1,260,600,000
Mar 31, 2011	1,124,000,000
Dec 31, 2010	1,438,100,000
Sep 30, 2010	1,219,800,000
Jun 30, 2010	1,187,200,000
Mar 31, 2010	1,039,100,000
Dec 31, 2009	1,216,700,000
Sep 30, 2009	1,122,100,000
Jun 30, 2009	1,040,400,000
Mar 31, 2009	947,300,000
Dec 31, 2008	1,059,300,000
Sep 30, 2008	953,000,000
Jun 30, 2008	951,500,000
Mar 31, 2008	877,100,000
Dec 31, 2007	953,600,000
Sep 30, 2007	844,500,000
Jun 30, 2007	854,400,000
Mar 31, 2007	834,200,000
Dec 31, 2006	858,000,000
Sep 30, 2006	755,700,000
Jun 30, 2006	774,800,000
Mar 31, 2006	740,800,000
Dec 31, 2005	809,900,000
Sep 30, 2005	751,000,000
Jun 30, 2005	762,400,000
Mar 31, 2005	702,200,000
Dec 31, 2004	705,500,000
Sep 30, 2004	654,800,000
Jun 30, 2004	684,200,000
Mar 31, 2004	646,600,000
Dec 31, 2003	710,000,000
Sep 30, 2003	568,100,000
Jun 30, 2003	542,500,000
Mar 31, 2003	529,600,000
Dec 31, 2002	574,300,000
Sep 30, 2002	526,700,000
Jun 30, 2002	545,500,000
Mar 31, 2002	502,800,000
Dec 31, 2001	589,900,000
Sep 30, 2001	566,000,000